What is the appropriate fosfomycin dosing regimen for an adult with an uncomplicated Escherichia coli urinary tract infection and normal renal function?

Fosfomycin Dosing for E. coli UTI

For uncomplicated E. coli cystitis in adults with normal renal function, administer fosfomycin tromethamine 3 grams as a single oral dose. 1

Indication and Dosing

Fosfomycin is FDA-approved specifically for uncomplicated urinary tract infections (acute cystitis) in women caused by susceptible E. coli and Enterococcus faecalis. 1 The standard regimen is:

• Single dose of 3 grams orally 1
• May be taken with or without food 1
• Must be mixed with water before ingesting (never take dry form) 1

This single-dose regimen achieves mean peak urinary concentrations of 706 mcg/mL within 2-4 hours, maintaining concentrations >100 mcg/mL for 48-72 hours after administration. 1 These urinary levels far exceed the MIC for most E. coli strains, providing effective bactericidal activity. 1

Critical Limitation: Not for Pyelonephritis

Fosfomycin should NOT be used for pyelonephritis or febrile UTI. 2 The 2024 European Association of Urology guidelines explicitly state that oral fosfomycin should be avoided for uncomplicated pyelonephritis due to insufficient efficacy data. 2 For pyelonephritis, fluoroquinolones and cephalosporins are the only recommended oral agents. 2

Renal Function Considerations

No dosage adjustment is required in elderly patients or those with normal renal function. 1 However, in patients with renal impairment:

• The elimination half-life increases significantly (from 11 hours to 50 hours as creatinine clearance decreases) 1
• Urinary recovery decreases from 32% to 11% in severe renal impairment 1
• While the FDA label doesn't mandate dose adjustment, reduced renal excretion may impact efficacy for UTI treatment 1

Clinical Efficacy

Single-dose fosfomycin demonstrates comparable efficacy to longer courses of other antibiotics for uncomplicated cystitis. 2 Clinical trials show similar cure rates when compared to:

• 3-day courses of fluoroquinolones 2
• 5-day courses of nitrofurantoin 2
• 3-day courses of trimethoprim-sulfamethoxazole 2

The microbiological efficacy rate for acute uncomplicated cystitis is approximately 95-98% at 15 days post-treatment. 3

Important Caveats

If bacteriuria persists or reappears after fosfomycin treatment, select alternative therapeutic agents rather than repeating fosfomycin. 1 The FDA label specifically warns against re-treatment with fosfomycin for treatment failures. 1

Drug interactions to consider:

• Avoid co-administration with metoclopramide, which significantly lowers serum concentrations and urinary excretion of fosfomycin 1
• Cimetidine does not affect fosfomycin pharmacokinetics 1

Resistance Considerations

Fosfomycin maintains excellent activity against multidrug-resistant E. coli, including ESBL-producing and carbapenem-resistant strains, with resistance rates typically <1%. 4 There is no cross-resistance with beta-lactams or aminoglycosides due to its unique mechanism of action (inhibition of MurA enzyme in cell wall synthesis). 4

The recent EUCAST reduction of the susceptibility breakpoint from 32 mg/L to 8 mg/L for E. coli may increase appropriate targeted use when MIC data are available. 5

Safety Profile

Fosfomycin demonstrates favorable tolerability with drug-related adverse events occurring in only 5.6% of patients, most commonly diarrhea. 3 It is classified as pregnancy category B and can be safely used in pregnant patients. 6